Five Prime Therapeutics reported $0 in Loan Capital for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amgen AMGN:US $ 33291M 4833M
AstraZeneca AZN:LN 28939M 4338M
Astrazeneca AZN:US 28.94B 4.34B
Bristol Myers Squibb BMY:US $ 39677M 2826M
Clovis Oncology CLVS:US $ 599.54M 16.41M
Cytokinetics CYTK:US $ 124.09M 3.8M
Daiichi Sankyo 4568:JP Y 143254M 20093M
Eli Lilly And LLY:US $ 15522.4M 785.8M
GlaxoSmithKline GSK:LN 20736M 294M
Glaxosmithkline GSK:US $ 20736M 294M
Halozyme Therapeutics HALO:US $ 786.45M 0.88M
IONIS PHARMACEUT IONS:US $ 1303M 62.3M
Ironwood Pharmaceuticals IRWD:US $ 333.21M 4.06M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Macrogenics MGNX:US $ 0 0
Novartis NOVN:VX SF 24715M 1776M
Novartis NVS:US $ 24715M 1776M
Sangamo Biosciences SGMO:US $ 0M 0M
Xencor XNCR:US $ 0M 0M